Harrow, Inc. financial data

Symbol
HROW, HROWL, HROWM on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 A Burton Hills Blvd, Suite 200, Nashville, TN
State of incorporation
DE
Fiscal year end
December 31
Former names
HARROW HEALTH, INC. (to 9/20/2023), Imprimis Pharmaceuticals, Inc. (to 12/17/2018), TRANSDEL PHARMACEUTICALS INC (to 2/27/2012), Bywater Resources, Inc (to 9/12/2007)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 214 % -35.6%
Quick Ratio 14.6 % -57.5%
Debt-to-equity 445 % -0.19%
Return On Equity -28.5 % +44.7%
Return On Assets -5.21 % +44.5%
Operating Margin 4.42 % +1235%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.7M shares +0.82%
Common Stock, Shares, Outstanding 35.6M shares +1.29%
Entity Public Float 678M USD +46.1%
Common Stock, Value, Issued 35K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.7M shares +9.3%
Weighted Average Number of Shares Outstanding, Diluted 35.7M shares +9.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 200M USD +53.3%
Research and Development Expense 12.2M USD +83.9%
Costs and Expenses 120K USD
Operating Income (Loss) 8.82M USD +1947%
Nonoperating Income (Expense) -26.1M USD -8.29%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.3M USD +27%
Income Tax Expense (Benefit) 20K USD -98.7%
Net Income (Loss) Attributable to Parent -17.5M USD +28.4%
Earnings Per Share, Basic -0.49 USD/shares +34.7%
Earnings Per Share, Diluted -0.49 USD/shares +34.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.2M USD -36.2%
Accounts Receivable, after Allowance for Credit Loss, Current 116M USD +221%
Inventory, Net 10.7M USD -1.52%
Other Assets, Current 3.41M USD +94.5%
Assets, Current 190M USD +36%
Property, Plant and Equipment, Net 3.73M USD +6.05%
Operating Lease, Right-of-Use Asset 8.55M USD +26.1%
Intangible Assets, Net (Excluding Goodwill) 185M USD +15.7%
Goodwill 332K USD 0%
Assets 389M USD +24.6%
Employee-related Liabilities, Current 9.5M USD +74.2%
Accrued Liabilities, Current 59K USD
Contract with Customer, Liability, Current 44K USD -41.3%
Liabilities, Current 91.3M USD +85.1%
Operating Lease, Liability, Noncurrent 8.79M USD +34.8%
Liabilities 320M USD +32.2%
Retained Earnings (Accumulated Deficit) -151M USD -13.1%
Stockholders' Equity Attributable to Parent 69.7M USD -1.57%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 69.3M USD -1.58%
Liabilities and Equity 389M USD +24.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.63M USD +43.7%
Net Cash Provided by (Used in) Financing Activities -809K USD -101%
Net Cash Provided by (Used in) Investing Activities -110K USD +99.9%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 35.6M shares +1.29%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.55M USD +92.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 72.6M USD +10.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.34M USD +58.4%
Deferred Tax Assets, Valuation Allowance 17.6M USD +12.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 9.29M USD +26.7%
Depreciation 351K USD +21%
Payments to Acquire Property, Plant, and Equipment 92K USD -81.5%
Lessee, Operating Lease, Liability, to be Paid 13.5M USD +31%
Property, Plant and Equipment, Gross 14.7M USD +8.5%
Operating Lease, Liability, Current 497K USD -38.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.55M USD +41.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.22M USD -3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +15.2%
Deferred Income Tax Expense (Benefit) -288K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.17M USD +41.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.43M USD +27.9%
Deferred Tax Assets, Operating Loss Carryforwards 2.45M USD -47.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.86M USD +1.28%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.29M USD +32.5%
Operating Lease, Payments 1.3M USD +5.69%
Additional Paid in Capital 221M USD +8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 11.8M USD +16.9%
Deferred Tax Assets, Net of Valuation Allowance 17.6M USD +12.7%
Share-based Payment Arrangement, Expense 17.6M USD +12.3%
Interest Expense 22M USD +116%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%